NCT00004985
Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2000
Completion: Not specified